DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
IMA-026
1
Unknown
Investigational
Unknown
Unknown
Asthma
Unknown
IMA-026
×
Maximum Phase:
1
First Approval:
None
UNII:
P52JII7PAL
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUCARESOL
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
TUCARESOL
×
Maximum Phase:
1
First Approval:
None
UNII:
JH368G5B9M
Molecule Type:
Small molecule
Molecular Formula:
C15H12O5
Molecular Weight:
272.26
AlogP:
2.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
RG-7256
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase B-raf inhibitor
RG-7256
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04620110
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Unknown
PF-04620110
×
Maximum Phase:
1
First Approval:
None
UNII:
CQ4M18RLJW
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O4
Molecular Weight:
396.45
AlogP:
2.85
PSA:
118.64
HBD:
2.0
HBA:
#RotB:
4.0
Source:
2,3-DIMERCAPTO-1-PROPANESULFONIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Hepatolenticular Degeneration
Unknown
2,3-DIMERCAPTO-1-PROPANESULFONIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
086L82361J
Molecule Type:
Small molecule
Molecular Formula:
C3H8O3S3
Molecular Weight:
188.29
AlogP:
0.1
PSA:
54.37
HBD:
3.0
HBA:
#RotB:
3.0
Source:
DIRLOTAPIDE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
DIRLOTAPIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
578H0RMP25
Molecule Type:
Small molecule
Molecular Formula:
C40H33F3N4O3
Molecular Weight:
674.72
AlogP:
8.25
PSA:
83.44
HBD:
2.0
HBA:
#RotB:
9.0
Source:
NONA-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONA-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
PK7O6W0U44
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RX-0201
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RX-0201
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TILVESTAMAB
1
Antibody
Investigational
Unknown
Unknown
Ovarian Neoplasms
Unknown
TILVESTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
IZK2TH7X5M
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
AZD-4573
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD-4573
×
Maximum Phase:
1
First Approval:
None
UNII:
E5XSP3X68B
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClN5O2
Molecular Weight:
429.95
AlogP:
3.81
PSA:
88.91
HBD:
2.0
HBA:
#RotB:
4.0
Source:
KHK-2866
1
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Proheparin-binding EGF-like growth factor inhibitor
KHK-2866
×
Maximum Phase:
1
First Approval:
None
UNII:
111EN0IJ7C
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
AZD3043
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD3043
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHA-543613
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
PHA-543613
×
Maximum Phase:
1
First Approval:
None
UNII:
R36R9KVD6Y
Molecule Type:
Small molecule
Molecular Formula:
C15H17N3O2
Molecular Weight:
271.32
AlogP:
1.65
PSA:
58.37
HBD:
1.0
HBA:
#RotB:
2.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
LGD-6972
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
LGD-6972
×
Maximum Phase:
1
First Approval:
None
UNII:
6IJ842I0Z2
Molecule Type:
Small molecule
Molecular Formula:
C43H46N2O5S
Molecular Weight:
702.92
AlogP:
8.83
PSA:
112.57
HBD:
3.0
HBA:
#RotB:
11.0
Source:
IRGD
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal
Unknown
IRGD
×
Maximum Phase:
1
First Approval:
None
UNII:
Z8MXU5GH4Q
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEP-9722
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell; Neoplasms
Unknown
CEP-9722
×
Maximum Phase:
1
First Approval:
None
UNII:
B68083E4YG
Molecule Type:
Small molecule
Molecular Formula:
C24H26N4O3
Molecular Weight:
418.5
AlogP:
2.62
PSA:
68.88
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOSATUXIZUMAB VEDOTIN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
LOSATUXIZUMAB VEDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
17C83BVV62
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALOFANIB
1
Small molecule
Investigational
Unknown
Unknown
Stomach Neoplasms
Unknown
ALOFANIB
×
Maximum Phase:
1
First Approval:
None
UNII:
LQX7RFK8MZ
Molecule Type:
Small molecule
Molecular Formula:
C19H15N3O6S
Molecular Weight:
413.41
AlogP:
3.46
PSA:
139.5
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ASP1235
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ASP1235
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEMLIMOGENE MEROLISBAC
1
Gene
Investigational
Unknown
Unknown
Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung
Unknown
PEMLIMOGENE MEROLISBAC
×
Maximum Phase:
1
First Approval:
None
UNII:
S2EGO8116S
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHROMIUM PICOLINATE
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Feeding and Eating Disorders
Unknown
CHROMIUM PICOLINATE
×
Maximum Phase:
1
First Approval:
None
UNII:
S71T8B8Z6P
Molecule Type:
Small molecule
Molecular Formula:
C18H12CrN3O6
Molecular Weight:
417.25
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ST1535
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A2a receptor antagonist
ST1535
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H16N8
Molecular Weight:
272.32
AlogP:
0.87
PSA:
100.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SYM-022
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SYM-022
×
Maximum Phase:
1
First Approval:
None
UNII:
7TQ52FVC2L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
88
89
90
91
92
93
94
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA